z-logo
open-access-imgOpen Access
Determination of oxidative stress markers and their importance in early diagnosis of uremia-related complications
Author(s) -
V. Kolagal,
S. Karanam,
Praveen K Dharmavarapu,
Roshan D'Souza,
Sharmila Upadhya,
Vivek Kumar,
Vivekananda Kedage,
Manjunatha S. Muttigi,
Jeevan K. Shetty,
Mungli Prakash
Publication year - 2009
Publication title -
indian journal of nephrology/indian journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.317
H-Index - 24
eISSN - 1998-3662
pISSN - 0971-4065
DOI - 10.4103/0971-4065.50673
Subject(s) - uremia , ceruloplasmin , oxidative stress , medicine , creatinine , endocrinology , hemodialysis , albumin , population , gastroenterology , environmental health
The existence of oxidative stress and the higher incidence of cardiovascular diseases in association with uremia is well proved. The uremic status of serum copper, ceruloplasmin (CP), protein thiols, malonyldialdehyde (MDA), and glutathione S-transferase (GST) levels was studied. The study was carried out on 51 chronic renal failure (CRF) patients who were not on hemodialysis therapy and on 42 healthy controls. Serum urea, creatinine, and MDA levels were found to be significantly increased (P < 0.001), and total protein, albumin, protein thiols, and copper levels were found to be significantly decreased in CRF patients compared to normal controls (P < 0.001). Ceruloplasmin levels were decreased significantly (P < 0.05), and there was no significant change in serum GST levels in CRF patients compared to normal controls. In conclusion, the significant increase in levels of MDA, and the decrease in levels of protein thiols, CP, and copper in uremia patients when compared to controls, reconfirms the presence of stress in this patient population. In view of the changes in other markers of oxidative stress, this absence of any significant change in the activity of GST in uremia patients compared to controls, warrants further study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here